The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021

Sara E. Oliver, Julia W. Gargano, Heather M. Scobie, Megan Wallace, Stephen C. Hadler, Jessica W. T. Leung, Amy Blain, Nancy McClung, Doug Campos‐Outcalt, Rebecca L. Morgan,

MMWR Morbidity and Mortality Weekly Report · 2021 · 171 citations · 1 references

DOIFull text

Open access

Concepts

Abstract

the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Janssen COVID-19 (Ad.26.COV2.S) vaccine (Janssen Biotech, Inc, a Janssen Pharmaceutical company, Johnson & Johnson; New

References

1